WHO ICTRP trial
A single-dose safety and pharmacokinetic study of ReliBeta® ((Interferon…
CTRI/2018/02/011802 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2018/02/011802 |
|---|---|
| Public title | A single-dose safety and pharmacokinetic study of ReliBeta® ((Interferon beta-1a 2x30 micrograms pre-filled syringe) in healthy adults. |
| Scientific title | A single arm, single-dose, safety and pharmacokinetic study of ReliBeta® (Interferon beta-1a 2x30 micrograms pre-filled syringe) from Reliance Life Sciences Pvt. Ltd., India in normal, healthy, adult, human subjects under fasting conditions. |
| Primary sponsor | Reliance Life Sciences Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | BA/BE |
| Countries | India |
| Interventions | Intervention1: ReliBeta® containing interferon beta-1a 2x30 micrograms in pre-filled glass syringe with 0.5 ml fill volume (i.e. 2 injections of interferon beta-1a 30 micrograms in pre-filled glass syringes): Dosage form: Solution for… |
| Registration date | Sep 2, 2018 |
| Target size | 20 |
| Secondary IDs | RLS/0114/001; Version 1.0, dated: 30th May 2014 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: